Human New Material (Stock Code: 301683) will land on ChiNext board on April 01, 2026.

Human New Material is publicly offering 15.7791 million shares, including 15.7791 million IPO shares offered at 78.38 yuan per share and raising funds of 1.237 billion yuan. The post-public-offering share capital of Human New Material is 63.1164 million shares in total. Guangzhou Human New Material Science and Technology Co., Ltd. principally engages in the research, production and sale of functional resins and functional coating materials. In 2024, its operating income reached 817 million yuan with the net profit of 145.7866 million yuan.